QNRX ▲ +8.2% - Quoin Pharmaceuticals, Ltd. $QNRX - Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome Quoin Pharmaceuticals shares rose 8.2% after the company announced it received FDA Fast Track designation for QRX003, its candidate for treating peeling skin syndrome. Fast Track status expedites the development and review process for drugs addressing serious conditions with unmet medical needs, typically viewed as a positive catalyst for clinical-stage biotech companies. 22-SEP-2026 08:30 AM ET